Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15374870 | 0.99 | ALOX5AP (0.39) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL14767335 | 0.99 | ALOX5AP (0.39) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL17951018 | 0.97 | ALOX5AP (0.40) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL12624690 | 0.96 | ALOX5AP (0.39) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL15933152 | 0.95 | ALOX5AP (0.34) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL2741563 | 0.95 | ALOX5AP (0.34) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL17951017 | 0.94 | PDE3B (0.34) | ALOX5APFEN1GRM2PDE3BPDE3A | |
| SCHEMBL12625439 | 0.94 | ALOX5AP (0.36) | ALOX5APFEN1GPR3ERN1PDE3B | |
| SCHEMBL14235285 | 0.92 | ALOX5AP (0.39) | ALOX5APFEN1GPR3GRM2ERN1 | |
| SCHEMBL11891864 | 0.91 | ALOX5AP (0.39) | ALOX5APFEN1GPR3GRM2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190185747-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | US | disclosed |
| US-9938462-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2018-04-10 | — | — | US | disclosed |
| US-9790426-B2 | Components for high-frequency technology, and liquid-crystalline media | MERCK PATENT GMBH (DE) | 2017-10-17 | — | — | US | disclosed |
| WO-2017162707-A1 | CYANOPYRIMIDINE DERIVATIVES SUITABLE AS COMPONENTS IN LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH (DE) | 2017-09-28 | — | — | WO | disclosed |
| US-9752077-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2017-09-05 | — | — | US | disclosed |
| US-9540566-B2 | Devices for high-frequency technology, liquid-crystalline media and compounds | MERCK PATENT GMBH (DE) | 2017-01-10 | — | — | US | disclosed |
| US-9523037-B2 | Liquid-crystalline media, components for high-frequency technology, and mesogenic compounds | MERCK PATENT GMBH (DE) | 2016-12-20 | — | — | US | disclosed |
| US-9296948-B2 | Mesogenic compounds, liquid-crystalline media and components for high-frequency technology | MERCK PATENT GMBH (DE) | 2016-03-29 | — | — | US | disclosed |
| US-20160046866-A1 | DEVICES FOR HIGH-FREQUENCY TECHNOLOGY, LIQUID-CRYSTALLINE MEDIA AND COMPOUNDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2016-02-18 | — | — | US | disclosed |
| US-20160002533-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2016-01-07 | — | — | US | disclosed |
| US-9193905-B2 | Devices for high-frequency technology, liquid-crystalline media and compounds | MERCK PATENT GMBH (DE) | 2015-11-24 | — | — | US | disclosed |
| US-20150322344-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
| US-20140021405-A1 | MESOGENIC COMPOUNDS, LIQUID-CRYSTALLINE MEDIA AND COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY | MERCK PATENT GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20130292608-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2013-11-07 | — | — | US | disclosed |
| WO-2011035863-A1 | COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY AND LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH (DE) | 2011-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046866-A1 | DEVICES FOR HIGH-FREQUENCY TECHNOLOGY, LIQUID-CRYSTALLINE MEDIA AND COMPOUNDS | MCM5, MCM3, MCM7 | ALOX5AP 2044/4885FEN1 3313/4885GPR3 1579/4885 |
| US-20150322344-A1 | LIQUID-CRYSTALLINE MEDIA, COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND MESOGENIC COMPOUNDS | MIF, SFRP1, MCM3 | ALOX5AP 3739/4885FEN1 3855/4885GPR3 1868/4885 |
| US-20190185747-A1 | LIQUID-CRYSTALLINE MEDIUM | CCNI, CCNT2, C1QBP | ALOX5AP 3096/4885FEN1 4227/4885GPR3 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.